The global Multi-disease Fundus Imaging-assisted Diagnostic System market was valued at US$ 1865 million in 2025 and is anticipated to reach US$ 3286 million by 2032, at a CAGR of 8.5% from 2026 to 2032.

Multi-disease Fundus Imaging-assisted Diagnostic System Market

Multi-disease Fundus Imaging-assisted Diagnostic System refers to medical software that uses artificial intelligence technology, especially deep learning algorithms, to automatically analyze eye images, enabling early detection of eye diseases, assisted diagnosis, and health risk assessment. This type of software can quickly identify characteristics of various eye diseases such as diabetic retinopathy, glaucoma, and age-related macular degeneration. Its core value lies in improving screening efficiency and consistency, assisting doctors in making judgments, and helping to extend high-quality ophthalmological diagnostic capabilities to resource-scarce areas.

Multi-disease Fundus Imaging-assisted Diagnostic System has a promising future and is at a critical stage of evolution from "single-disease assisted detection" to "comprehensive multi-disease assessment and systemic health early warning." The market growth drivers are clear: the increase in the global diabetic population and the aging population has driven up the rigid demand for early eye disease screening; continuous advancements in deep learning technology have improved the accuracy and reliability of algorithms; and supportive regulatory policies and exploration of medical insurance reimbursement are accelerating its clinical implementation. In the future, this field will exhibit three major trends: First, technological integration, which will be combined with portable devices and telemedicine platforms to expand screening scenarios from hospitals to grassroots communities and even homes; second, functional diversification, extending from single eye disease screening to predicting disease progression and assessing overall health; and third, ecosystem systematization, integrating into the closed loop of "prevention-screening-diagnosis-management" and becoming an important digital infrastructure for eye health and even chronic disease management systems.

The North American market for Multi-disease Fundus Imaging-assisted Diagnostic System is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Multi-disease Fundus Imaging-assisted Diagnostic System is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Multi-disease Fundus Imaging-assisted Diagnostic System in Hospitals is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Multi-disease Fundus Imaging-assisted Diagnostic System include AEYE Health, RetinaLyze, DeepMind, Remidio, RetinAI, RetinaRisk, Eyenuk, Inc., Synapxe, Intelligent Retinal Imaging Systems, Retmarker, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Multi-disease Fundus Imaging-assisted Diagnostic System market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Multi-disease Fundus Imaging-assisted Diagnostic System. The Multi-disease Fundus Imaging-assisted Diagnostic System market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Multi-disease Fundus Imaging-assisted Diagnostic System market comprehensively. Regional market sizes by Type, by Application, by Technology/Imaging Fundamentals, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Multi-disease Fundus Imaging-assisted Diagnostic System manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Multi-disease Fundus Imaging-assisted Diagnostic System Market Report

Report Metric	Details
Report Name	Multi-disease Fundus Imaging-assisted Diagnostic System Market
Accounted market size in 2025	US$ 1865 million
Forecasted market size in 2032	US$ 3286 million
CAGR	8.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	On-premise Cloud-based
Segment by Technology/Imaging Fundamentals	AI Based on Fundus Images AI Based on OCT
Segment by Core Functions	Disease Screening and Assisted Diagnosis Software Systemic Health Risk Assessment Software
Segment by Deployment and Usage Modes	Embedded System Integrated into Professional Equipment SaaS Service Based on Cloud Platform Mobile/Portable Applications
Segment by Application	Hospitals Clinics
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AEYE Health, RetinaLyze, DeepMind, Remidio, RetinAI, RetinaRisk, Eyenuk, Inc., Synapxe, Intelligent Retinal Imaging Systems, Retmarker, CSIRO, WeDoctor Group, VoxelCloud, Zhenhealth, Tencent Health, Airdoc, Silicon Intelligence, Zhiyuan Huitu, Kangfuzi Health
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Technology/Imaging Fundamentals, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Multi-disease Fundus Imaging-assisted Diagnostic System companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Multi-disease Fundus Imaging-assisted Diagnostic System Market growing?

Ans: The Multi-disease Fundus Imaging-assisted Diagnostic System Market witnessing a CAGR of 8.5% during the forecast period 2026-2032.

What is the Multi-disease Fundus Imaging-assisted Diagnostic System Market size in 2032?

Ans: The Multi-disease Fundus Imaging-assisted Diagnostic System Market size in 2032 will be US$ 3286 million.

Who are the main players in the Multi-disease Fundus Imaging-assisted Diagnostic System Market report?

Ans: The main players in the Multi-disease Fundus Imaging-assisted Diagnostic System Market are AEYE Health, RetinaLyze, DeepMind, Remidio, RetinAI, RetinaRisk, Eyenuk, Inc., Synapxe, Intelligent Retinal Imaging Systems, Retmarker, CSIRO, WeDoctor Group, VoxelCloud, Zhenhealth, Tencent Health, Airdoc, Silicon Intelligence, Zhiyuan Huitu, Kangfuzi Health

What are the Application segmentation covered in the Multi-disease Fundus Imaging-assisted Diagnostic System Market report?

Ans: The Applications covered in the Multi-disease Fundus Imaging-assisted Diagnostic System Market report are Hospitals, Clinics

What are the Type segmentation covered in the Multi-disease Fundus Imaging-assisted Diagnostic System Market report?

Ans: The Types covered in the Multi-disease Fundus Imaging-assisted Diagnostic System Market report are On-premise, Cloud-based

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 On-premise

1.2.3 Cloud-based

1.3 Market by Technology/Imaging Fundamentals

1.3.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Technology/Imaging Fundamentals: 2021 vs 2025 vs 2032

1.3.2 AI Based on Fundus Images

1.3.3 AI Based on OCT

1.4 Market by Core Functions

1.4.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Core Functions: 2021 vs 2025 vs 2032

1.4.2 Disease Screening and Assisted Diagnosis Software

1.4.3 Systemic Health Risk Assessment Software

1.5 Market by Deployment and Usage Modes

1.5.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Deployment and Usage Modes: 2021 vs 2025 vs 2032

1.5.2 Embedded System Integrated into Professional Equipment

1.5.3 SaaS Service Based on Cloud Platform

1.5.4 Mobile/Portable Applications

1.6 Market by Application

1.6.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth by Application: 2021 vs 2025 vs 2032

1.6.2 Hospitals

1.6.3 Clinics

1.7 Assumptions and Limitations

1.8 Study Objectives

1.9 Years Considered

2 Global Growth Trends

2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Perspective (2021–2032)

2.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Growth Trends by Region

2.2.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Multi-disease Fundus Imaging-assisted Diagnostic System Historic Market Size by Region (2021–2026)

2.2.3 Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Region (2027–2032)

2.3 Multi-disease Fundus Imaging-assisted Diagnostic System Market Dynamics

2.3.1 Multi-disease Fundus Imaging-assisted Diagnostic System Industry Trends

2.3.2 Multi-disease Fundus Imaging-assisted Diagnostic System Market Drivers

2.3.3 Multi-disease Fundus Imaging-assisted Diagnostic System Market Challenges

2.3.4 Multi-disease Fundus Imaging-assisted Diagnostic System Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Multi-disease Fundus Imaging-assisted Diagnostic System Players by Revenue

3.1.1 Global Top Multi-disease Fundus Imaging-assisted Diagnostic System Players by Revenue (2021–2026)

3.1.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Players (2021–2026)

3.2 Global Top Multi-disease Fundus Imaging-assisted Diagnostic System Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Multi-disease Fundus Imaging-assisted Diagnostic System Revenue

3.4 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Concentration Ratio

3.4.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Multi-disease Fundus Imaging-assisted Diagnostic System Revenue in 2025

3.5 Global Key Players of Multi-disease Fundus Imaging-assisted Diagnostic System Head Offices and Areas Served

3.6 Global Key Players of Multi-disease Fundus Imaging-assisted Diagnostic System, Products and Applications

3.7 Global Key Players of Multi-disease Fundus Imaging-assisted Diagnostic System, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Multi-disease Fundus Imaging-assisted Diagnostic System Breakdown Data by Type

4.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Historic Market Size by Type (2021–2026)

4.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Type (2027–2032)

5 Multi-disease Fundus Imaging-assisted Diagnostic System Breakdown Data by Application

5.1 Global Multi-disease Fundus Imaging-assisted Diagnostic System Historic Market Size by Application (2021–2026)

5.2 Global Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021–2032)

6.2 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021–2026)

6.4 North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021–2032)

7.2 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021–2026)

7.4 Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021–2032)

8.2 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (2021–2026)

8.4 Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021–2032)

9.2 Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021–2026)

9.4 Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (2021–2032)

10.2 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2021–2026)

10.4 Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AEYE Health

11.1.1 AEYE Health Company Details

11.1.2 AEYE Health Business Overview

11.1.3 AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.1.4 AEYE Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.1.5 AEYE Health Recent Development

11.2 RetinaLyze

11.2.1 RetinaLyze Company Details

11.2.2 RetinaLyze Business Overview

11.2.3 RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.2.4 RetinaLyze Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.2.5 RetinaLyze Recent Development

11.3 DeepMind

11.3.1 DeepMind Company Details

11.3.2 DeepMind Business Overview

11.3.3 DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.3.4 DeepMind Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.3.5 DeepMind Recent Development

11.4 Remidio

11.4.1 Remidio Company Details

11.4.2 Remidio Business Overview

11.4.3 Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.4.4 Remidio Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.4.5 Remidio Recent Development

11.5 RetinAI

11.5.1 RetinAI Company Details

11.5.2 RetinAI Business Overview

11.5.3 RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.5.4 RetinAI Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.5.5 RetinAI Recent Development

11.6 RetinaRisk

11.6.1 RetinaRisk Company Details

11.6.2 RetinaRisk Business Overview

11.6.3 RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.6.4 RetinaRisk Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.6.5 RetinaRisk Recent Development

11.7 Eyenuk, Inc.

11.7.1 Eyenuk, Inc. Company Details

11.7.2 Eyenuk, Inc. Business Overview

11.7.3 Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.7.4 Eyenuk, Inc. Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.7.5 Eyenuk, Inc. Recent Development

11.8 Synapxe

11.8.1 Synapxe Company Details

11.8.2 Synapxe Business Overview

11.8.3 Synapxe Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.8.4 Synapxe Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.8.5 Synapxe Recent Development

11.9 Intelligent Retinal Imaging Systems

11.9.1 Intelligent Retinal Imaging Systems Company Details

11.9.2 Intelligent Retinal Imaging Systems Business Overview

11.9.3 Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.9.4 Intelligent Retinal Imaging Systems Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.9.5 Intelligent Retinal Imaging Systems Recent Development

11.10 Retmarker

11.10.1 Retmarker Company Details

11.10.2 Retmarker Business Overview

11.10.3 Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.10.4 Retmarker Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.10.5 Retmarker Recent Development

11.11 CSIRO

11.11.1 CSIRO Company Details

11.11.2 CSIRO Business Overview

11.11.3 CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.11.4 CSIRO Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.11.5 CSIRO Recent Development

11.12 WeDoctor Group

11.12.1 WeDoctor Group Company Details

11.12.2 WeDoctor Group Business Overview

11.12.3 WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.12.4 WeDoctor Group Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.12.5 WeDoctor Group Recent Development

11.13 VoxelCloud

11.13.1 VoxelCloud Company Details

11.13.2 VoxelCloud Business Overview

11.13.3 VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.13.4 VoxelCloud Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.13.5 VoxelCloud Recent Development

11.14 Zhenhealth

11.14.1 Zhenhealth Company Details

11.14.2 Zhenhealth Business Overview

11.14.3 Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.14.4 Zhenhealth Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.14.5 Zhenhealth Recent Development

11.15 Tencent Health

11.15.1 Tencent Health Company Details

11.15.2 Tencent Health Business Overview

11.15.3 Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.15.4 Tencent Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.15.5 Tencent Health Recent Development

11.16 Airdoc

11.16.1 Airdoc Company Details

11.16.2 Airdoc Business Overview

11.16.3 Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.16.4 Airdoc Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.16.5 Airdoc Recent Development

11.17 Silicon Intelligence

11.17.1 Silicon Intelligence Company Details

11.17.2 Silicon Intelligence Business Overview

11.17.3 Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.17.4 Silicon Intelligence Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.17.5 Silicon Intelligence Recent Development

11.18 Zhiyuan Huitu

11.18.1 Zhiyuan Huitu Company Details

11.18.2 Zhiyuan Huitu Business Overview

11.18.3 Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.18.4 Zhiyuan Huitu Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.18.5 Zhiyuan Huitu Recent Development

11.19 Kangfuzi Health

11.19.1 Kangfuzi Health Company Details

11.19.2 Kangfuzi Health Business Overview

11.19.3 Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Introduction

11.19.4 Kangfuzi Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

11.19.5 Kangfuzi Health Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Intelligent Retinal Imaging Systems

List of Tables

Table 1. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of On-premise

Table 3. Key Players of Cloud-based

Table 4. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Technology/Imaging Fundamentals (US$ Million): 2021 vs 2025 vs 2032

Table 5. Key Players of AI Based on Fundus Images

Table 6. Key Players of AI Based on OCT

Table 7. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Core Functions (US$ Million): 2021 vs 2025 vs 2032

Table 8. Key Players of Disease Screening and Assisted Diagnosis Software

Table 9. Key Players of Systemic Health Risk Assessment Software

Table 10. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Deployment and Usage Modes (US$ Million): 2021 vs 2025 vs 2032

Table 11. Key Players of Embedded System Integrated into Professional Equipment

Table 12. Key Players of SaaS Service Based on Cloud Platform

Table 13. Key Players of Mobile/Portable Applications

Table 14. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 15. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 16. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (US$ Million), 2021–2026

Table 17. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Region (2021–2026)

Table 18. Global Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Region (US$ Million), 2027–2032

Table 19. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Region (2027–2032)

Table 20. Multi-disease Fundus Imaging-assisted Diagnostic System Market Trends

Table 21. Multi-disease Fundus Imaging-assisted Diagnostic System Market Drivers

Table 22. Multi-disease Fundus Imaging-assisted Diagnostic System Market Challenges

Table 23. Multi-disease Fundus Imaging-assisted Diagnostic System Market Restraints

Table 24. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue by Players (US$ Million), 2021–2026

Table 25. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Players (2021–2026)

Table 26. Global Top Multi-disease Fundus Imaging-assisted Diagnostic System Players by Tier (Tier 1, Tier 2, and Tier 3), based on Multi-disease Fundus Imaging-assisted Diagnostic System Revenue, 2025

Table 27. Ranking of Global Top Multi-disease Fundus Imaging-assisted Diagnostic System Companies by Revenue (US$ Million) in 2025

Table 28. Global 5 Largest Players Market Share by Multi-disease Fundus Imaging-assisted Diagnostic System Revenue (CR5 and HHI), 2021–2026

Table 29. Global Key Players of Multi-disease Fundus Imaging-assisted Diagnostic System, Headquarters and Area Served

Table 30. Global Key Players of Multi-disease Fundus Imaging-assisted Diagnostic System, Products and Applications

Table 31. Global Key Players of Multi-disease Fundus Imaging-assisted Diagnostic System, Date of General Availability (GA)

Table 32. Mergers and Acquisitions, Expansion Plans

Table 33. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Type (US$ Million), 2021–2026

Table 34. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Type (2021–2026)

Table 35. Global Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Type (US$ Million), 2027–2032

Table 36. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Type (2027–2032)

Table 37. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (US$ Million), 2021–2026

Table 38. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Application (2021–2026)

Table 39. Global Multi-disease Fundus Imaging-assisted Diagnostic System Forecasted Market Size by Application (US$ Million), 2027–2032

Table 40. Global Multi-disease Fundus Imaging-assisted Diagnostic System Revenue Market Share by Application (2027–2032)

Table 41. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 42. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (US$ Million), 2021–2026

Table 43. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (US$ Million), 2027–2032

Table 44. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 45. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (US$ Million), 2021–2026

Table 46. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (US$ Million), 2027–2032

Table 47. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 48. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (US$ Million), 2021–2026

Table 49. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Region (US$ Million), 2027–2032

Table 50. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 51. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (US$ Million), 2021–2026

Table 52. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (US$ Million), 2027–2032

Table 53. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 54. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (US$ Million), 2021–2026

Table 55. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Country (US$ Million), 2027–2032

Table 56. AEYE Health Company Details

Table 57. AEYE Health Business Overview

Table 58. AEYE Health Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 59. AEYE Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 60. AEYE Health Recent Development

Table 61. RetinaLyze Company Details

Table 62. RetinaLyze Business Overview

Table 63. RetinaLyze Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 64. RetinaLyze Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 65. RetinaLyze Recent Development

Table 66. DeepMind Company Details

Table 67. DeepMind Business Overview

Table 68. DeepMind Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 69. DeepMind Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 70. DeepMind Recent Development

Table 71. Remidio Company Details

Table 72. Remidio Business Overview

Table 73. Remidio Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 74. Remidio Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 75. Remidio Recent Development

Table 76. RetinAI Company Details

Table 77. RetinAI Business Overview

Table 78. RetinAI Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 79. RetinAI Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 80. RetinAI Recent Development

Table 81. RetinaRisk Company Details

Table 82. RetinaRisk Business Overview

Table 83. RetinaRisk Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 84. RetinaRisk Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 85. RetinaRisk Recent Development

Table 86. Eyenuk, Inc. Company Details

Table 87. Eyenuk, Inc. Business Overview

Table 88. Eyenuk, Inc. Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 89. Eyenuk, Inc. Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 90. Eyenuk, Inc. Recent Development

Table 91. Synapxe Company Details

Table 92. Synapxe Business Overview

Table 93. Synapxe Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 94. Synapxe Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 95. Synapxe Recent Development

Table 96. Intelligent Retinal Imaging Systems Company Details

Table 97. Intelligent Retinal Imaging Systems Business Overview

Table 98. Intelligent Retinal Imaging Systems Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 99. Intelligent Retinal Imaging Systems Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 100. Intelligent Retinal Imaging Systems Recent Development

Table 101. Retmarker Company Details

Table 102. Retmarker Business Overview

Table 103. Retmarker Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 104. Retmarker Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 105. Retmarker Recent Development

Table 106. CSIRO Company Details

Table 107. CSIRO Business Overview

Table 108. CSIRO Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 109. CSIRO Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 110. CSIRO Recent Development

Table 111. WeDoctor Group Company Details

Table 112. WeDoctor Group Business Overview

Table 113. WeDoctor Group Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 114. WeDoctor Group Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 115. WeDoctor Group Recent Development

Table 116. VoxelCloud Company Details

Table 117. VoxelCloud Business Overview

Table 118. VoxelCloud Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 119. VoxelCloud Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 120. VoxelCloud Recent Development

Table 121. Zhenhealth Company Details

Table 122. Zhenhealth Business Overview

Table 123. Zhenhealth Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 124. Zhenhealth Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 125. Zhenhealth Recent Development

Table 126. Tencent Health Company Details

Table 127. Tencent Health Business Overview

Table 128. Tencent Health Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 129. Tencent Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 130. Tencent Health Recent Development

Table 131. Airdoc Company Details

Table 132. Airdoc Business Overview

Table 133. Airdoc Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 134. Airdoc Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 135. Airdoc Recent Development

Table 136. Silicon Intelligence Company Details

Table 137. Silicon Intelligence Business Overview

Table 138. Silicon Intelligence Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 139. Silicon Intelligence Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 140. Silicon Intelligence Recent Development

Table 141. Zhiyuan Huitu Company Details

Table 142. Zhiyuan Huitu Business Overview

Table 143. Zhiyuan Huitu Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 144. Zhiyuan Huitu Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 145. Zhiyuan Huitu Recent Development

Table 146. Kangfuzi Health Company Details

Table 147. Kangfuzi Health Business Overview

Table 148. Kangfuzi Health Multi-disease Fundus Imaging-assisted Diagnostic System Product

Table 149. Kangfuzi Health Revenue in Multi-disease Fundus Imaging-assisted Diagnostic System Business (US$ Million), 2021–2026

Table 150. Kangfuzi Health Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

Table 154. Authors List of This Report

List of Figures

Figure 1. Multi-disease Fundus Imaging-assisted Diagnostic System Picture

Figure 2. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Type: 2025 vs 2032

Figure 4. On-premise Features

Figure 5. Cloud-based Features

Figure 6. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Comparison by Technology/Imaging Fundamentals (US$ Million), 2021–2032

Figure 7. AI Based on Fundus Images Features

Figure 8. AI Based on OCT Features

Figure 9. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Comparison by Core Functions (US$ Million), 2021–2032

Figure 10. Disease Screening and Assisted Diagnosis Software Features

Figure 11. Systemic Health Risk Assessment Software Features

Figure 12. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size Comparison by Deployment and Usage Modes (US$ Million), 2021–2032

Figure 13. Embedded System Integrated into Professional Equipment Features

Figure 14. SaaS Service Based on Cloud Platform Features

Figure 15. Mobile/Portable Applications Features

Figure 16. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size by Application (US$ Million), 2021–2032

Figure 17. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Application: 2025 vs 2032

Figure 18. Hospitals Case Studies

Figure 19. Clinics Case Studies

Figure 20. Multi-disease Fundus Imaging-assisted Diagnostic System Report Years Considered

Figure 21. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 22. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 23. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Region: 2025 vs 2032

Figure 24. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Players in 2025

Figure 25. Global Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 26. The Top 10 and 5 Players Market Share by Multi-disease Fundus Imaging-assisted Diagnostic System Revenue in 2025

Figure 27. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. North America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021–2032)

Figure 29. United States Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Canada Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 32. Europe Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021–2032)

Figure 33. Germany Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. France Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. U.K. Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. Italy Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Russia Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Ireland Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 40. Asia-Pacific Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Region (2021–2032)

Figure 41. China Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Japan Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. South Korea Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 44. Southeast Asia Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. India Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. Australia & New Zealand Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 48. Latin America Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021–2032)

Figure 49. Mexico Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 50. Brazil Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 51. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 52. Middle East & Africa Multi-disease Fundus Imaging-assisted Diagnostic System Market Share by Country (2021–2032)

Figure 53. Israel Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 54. Saudi Arabia Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 55. UAE Multi-disease Fundus Imaging-assisted Diagnostic System Market Size YoY Growth (US$ Million), 2021–2032

Figure 56. AEYE Health Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 57. RetinaLyze Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 58. DeepMind Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 59. Remidio Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 60. RetinAI Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 61. RetinaRisk Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 62. Eyenuk, Inc. Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 63. Synapxe Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 64. Intelligent Retinal Imaging Systems Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 65. Retmarker Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 66. CSIRO Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 67. WeDoctor Group Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 68. VoxelCloud Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 69. Zhenhealth Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 70. Tencent Health Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 71. Airdoc Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 72. Silicon Intelligence Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 73. Zhiyuan Huitu Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 74. Kangfuzi Health Revenue Growth Rate in Multi-disease Fundus Imaging-assisted Diagnostic System Business (2021–2026)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions